PlainPharmaWatch

CMS Open Payments · Program Year 2024

Virginia

Virginia received $80,630,442.16 in pharmaceutical-industry payments to 17,575 physicians and 28 teaching hospitals across 387,262 transactions.

$80.6M
Total payments
$71.5M
To physicians
$3.4M
To teaching hospitals
#14
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $80.6M in payments to 17,575 physicians and 28 teaching hospitals in Virginia. That ranks Virginia #14 of 59 states and territories (0.6% of the US total), averaging $4.1K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Virginia pairs top-quartile payment volume with an overwhelmingly physician-directed payment mix.

#14
of 59 states
0.6%
of the national total
88.7%
to physicians vs. hospitals
17,575
physicians paid

What the Data Shows for Virginia

Virginia's Open Payments file is physician-weighted: 88.7% of $80.6M went to 17,575 physicians ($4.1K each), with 4.2% on 28 teaching hospitals.

On the national dollar ranking it is still #14 of 59 (0.6% of US payments). Average transaction $208.21. Leading nature of payment: "Acquisitions" at $25.5M (31.6% of the state file; top-three natures 62.8%).

Virginia sits in the 78th percentile (mid-pack). Just above: Tennessee ($81.9M). Just below: Arizona ($67.8M). For context: top-ranked California ($342.4M) is 4.2× larger than Virginia. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Virginia are distributed between physicians and teaching hospitals.

Physician Payments

$71.5M

88.7% of total · 17,575 recipients · $4.1K avg

Teaching Hospital Payments

$3.4M

4.2% of total · 28 hospitals · $119.9K avg

Payment Breakdown by Type

Virginia has 16 types of pharmaceutical payments. "Acquisitions" accounts for 31.6%.

Nature concentration in Virginia

Top three Open Payments natures are 62.8% of state dollars; residual is every other reported nature

Acquisitions$25.5MCompensation for Services Ot…$13.6MConsulting Fee$11.6MAll other natures (13)$30.0M

Payment categories in Virginia

Top categories by total reported dollar volume

1. Acquisitions$25.5M2. Compensation for Services…$13.6M3. Consulting Fee$11.6M4. Food and Beverage$10.1M5. Royalty or License$9.9M6. Travel and Lodging$4.6M7. Grant$1.1M8. Honoraria$926.5K9. Education$886.8K10. Long-Term Medical Supply…$800.9K
Payment Type Amount Transactions
Acquisitions $25.5M 10
Compensation for Services Other Than Consulting $13.6M 5,691
Consulting Fee $11.6M 4,153
Food and Beverage $10.1M 355,135
Royalty or License $9.9M 429
Travel and Lodging $4.6M 14,307
Grant $1.1M 146
Honoraria $926.5K 315
Education $886.8K 4,551
Long-Term Medical Supply or Device Loan $800.9K 560
Space Rental or Facility Fees $770.3K 249
Compensation for Faculty or Speaker (Medical Education) $510.4K 243
Debt Forgiveness $162.8K 53
Gift $135.7K 853
Entertainment $41.6K 554
Charitable Contribution $22.9K 13

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Virginia totals can and cannot tell you

The aggregate payment figure for Virginia measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Virginia's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.